Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay B Wish

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Nephrology News & Issues|January 26, 2013
The KDIGO anemia guideline: can reason triumph over regulation?Jay B Wish
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2014
The role of 30-day readmission as a measure of qualityJay B Wish
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 12, 2008
Intravenous iron: not just for hemodialysis patients anymoreJay B Wish
Seminars in Dialysis|September 29, 2016
What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: The Benefits of Intravenous IronJay B Wish
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
The approval process for biosimilar erythropoiesis-stimulating agentsJay B Wish
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2012
Are consistency and individualization mutually exclusive in erythropoiesis-stimulating agent therapy?Jay B Wish
American Journal of Nephrology|April 24, 2022
Debate: Are Hydroxylase Inhibitors Stabilizers a Viable Alternative to Erythropoiesis-Stimulating Agents in the Management of Anemia in CKD? CONJay B Wish
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 22, 2011
Hemoglobin variability as a predictor of mortality: What's a practitioner to do?Jay B Wish
Nephrology News & Issues|February 2, 2019
Emerging treatments for anemia in patients with CKD and ESRDJay B Wish
Nephrology News & Issues|August 21, 2008
New ESRD clinical performance measures and data collection system: progress and pitfallsJay B Wish
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Nephrology News & Issues|January 26, 2013
The KDIGO anemia guideline: can reason triumph over regulation?Jay B Wish
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2014
The role of 30-day readmission as a measure of qualityJay B Wish
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 12, 2008
Intravenous iron: not just for hemodialysis patients anymoreJay B Wish
Seminars in Dialysis|September 29, 2016
What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: The Benefits of Intravenous IronJay B Wish
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
The approval process for biosimilar erythropoiesis-stimulating agentsJay B Wish
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2012
Are consistency and individualization mutually exclusive in erythropoiesis-stimulating agent therapy?Jay B Wish
American Journal of Nephrology|April 24, 2022
Debate: Are Hydroxylase Inhibitors Stabilizers a Viable Alternative to Erythropoiesis-Stimulating Agents in the Management of Anemia in CKD? CONJay B Wish
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 22, 2011
Hemoglobin variability as a predictor of mortality: What's a practitioner to do?Jay B Wish
Nephrology News & Issues|February 2, 2019
Emerging treatments for anemia in patients with CKD and ESRDJay B Wish
Nephrology News & Issues|August 21, 2008
New ESRD clinical performance measures and data collection system: progress and pitfallsJay B Wish
Pageof 9